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Summary
Objective: To compare three radiographic techniques (ﬂuoroscopic semi-ﬂexed [Fluoro], ﬁxed ﬂexion [FF], and semi-ﬂexed metatarsophalan-
geal joint [MTP] views) for measuring medial joint space width (JSW) of the knee in longitudinal osteoarthritis (OA) trials and to identify the
percentage of patients with detectable progression.
Design: Retrospective summary of the progression and variability of the change in JSW in knee OA.
Material and methods: Data from the placebo arms of three separate, structure modifying, knee OA trials were compared including gender,
age, baseline JSW, change from baseline in JSW, duration of observation, and number and percent of patients with joint space narrowing of
various degrees. Computer evaluation of the joint space at its narrowest point in the medial compartment was used in the studies. It is impor-
tant to note that the narrowest joint space at baseline may not be in the same anatomic location at subsequent evaluations. No statistical tests
were performed.
Results: The average observation times were 0.98, 0.68 and 0.82 years for the Fluoro, FF, and MTP studies, respectively. The amount of
progression was different among the three studies. The Fluoro study showed the greatest magnitude of OA structural progression and the
lowest variability. The Fluoro study was expected to show the greatest magnitude of structural progression since it was conducted for the
longest duration. For all patients, the standard deviation of the change in JSW was 0.42, 0.63, and 0.53 mm for the Fluoro, FF, and MTP stud-
ies, respectively. The percent of patients with detectable progression was similar across studies.
Conclusion: With these data, information was not sufﬁcient to control for duration of observation and differences in inclusion criteria for the
three study populations. Therefore, no deﬁnitive conclusions can be made regarding the degree of progression of OA over speciﬁc time in-
tervals. However, the data indicate that all three studies contain a cohort of patients that exhibit detectable progression.
ª 2006 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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SocietyIntroduction
Osteoarthritis (OA) is a disorder of the synovial joints char-
acterized by focal loss of cartilage and reactive changes in
subchondral and marginal bone, synovium, and periarticu-
lar structures1e3. OA occurs in weight-bearing joints and
commonly affects the knee4. This disorder is associated
with age and obesity and results in joint pain and loss of
function. To determine the response to treatment, guide-
lines for clinical trials in patients with knee OA recommend
the use of radiography5,6, in which the minimum medial
tibiofemoral compartment joint space width (JSW) or inter-
bone distance is a surrogate measure for the thickness of
articular cartilage. Measurement of this feature assesses
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2006.Athe combination of both the material thickness of articular
cartilage and its compressibility when the joint is radio-
graphed in the standing position7. Various radiographic
techniques have been used to measure JSW to track the
progression of OA. We report a comparison of JSW data
obtained from the placebo arms of three separate knee
OA clinical trials that each used a different radiographic
method.
Patients and methods
Procter & Gamble Pharmaceuticals, Roche, and Bayer
each conducted a separate, structure modifying, knee OA
trial. The placebo data from these trials were analyzed to
examine the progression and variability of joint space nar-
rowing (JSN), as well as to identify the number and percent-
age of patients with detectable progression. Detectable
progression is progression that is outside of the measure-
ment error for the speciﬁc radiographic technique. Patients
in the Bayer and Roche trials were observed for variable
amounts of time since the trials were terminated early.32
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The Fluoro technique8 was utilized in the Procter &
Gamble Pharmaceuticals trial, which included 85 placebo
patients who fulﬁlled the American College of Rheumatol-
ogy (ACR) criteria for the diagnosis of knee OA (age> 50
years, morning knee stiffness< 30 min, or knee crepitus)
and were imaged at four radiographic facilities serving 15
clinical sites in the United Kingdom. A target knee was iden-
tiﬁed by selecting a knee with knee pain on most days dur-
ing at least 1 month out of the previous 3 months, presence
of at least one osteophyte (medial, lateral, or tibial spine),
minimum medial JSW between 2 and 4 mm, and medial
compartment narrower than the lateral compartment. Key
exclusion criteria included secondary OA and the following
for the target knee: hyaluronic acid or corticosteroid injec-
tion, knee injury or diagnostic arthroscopy within the previ-
ous 6 months, or history of knee surgery. The trial
duration was 12 months with radiographs obtained at base-
line and at 12 months.
Each knee was exposed on a separate ﬁlm with a 5-mm
metal ball to allow magniﬁcation correction. Repeat posi-
tioning was aided by using a hand-drawn foot map for
each patient. All participating radiographers had been pro-
vided with training and were required to qualify by producing
a pair of radiographic images taken within 2e7 days apart of
the target knee of ﬁve patients. In order to qualify, none of
the ﬁlm pairs could have a difference in minimum medial
compartment JSW of more than 0.5 mm. Imaging quality
assurance (QA), image analysis, and bar coding were all
performed at a central radiology service, the Regional Qual-
ity Control Centre (Amsterdam University, Amsterdam, The
Netherlands). Image quality assessment included anatomi-
cal coverage of the knee; positioning and projection of the
joint space; presence of signiﬁcant artifacts; and delineation
of cortical and trabecular bone, particularly the femorotibial
articular surfaces. If images did not meet the QA require-
ments they were rejected, and the corresponding patients
rescheduled for repeat radiography. The image rejection
rate for the study was 3.3%, i.e., 3.3% of the images were
unacceptable and required repeat radiography. At the cen-
tral analysis facility at King’s College London, analog ﬁlm
images were digitized to a resolution of 100 m and stored
in a central database. A fully automated software program
detected and measured the image of the metal ball used
for correcting the effect of radiographic magniﬁcation. Mini-
mum JSW was then measured using semi-automated
software integrated with the central image database. This
software automatically delineated the articular surfaces of
the medial and lateral femorotibial compartments and mea-
sured JSW at the point of minimum distance in each com-
partment. Computer measurements were veriﬁed and
edited, if necessary, to ensure correct delineation of the ar-
ticular surfaces and selection of measurement sites that ex-
cluded marginal osteophytes and that were restricted to the
weight-bearing portions of the femorotibial joints. Images
were measured individually rather than in serial pairs, and
the readers were blinded to patient information and the
chronology of the images8.
FIXED FLEXION (FF) TECHNIQUE
The FF technique9 was utilized in the Roche trial, which in-
cluded 99 placebo patients who fulﬁlled the ACR criteria for
OA. Images were acquired from 58 sites in the US. A target
knee was identiﬁed by selecting a knee with grade 1 or grade
2 JSN of the medial compartment as deﬁned by theOsteoarthritis Research Society (OARS) Atlas10; medial
and lateral compartment JSW2 mm; grade 1, 2, or 3 osteo-
phytes as deﬁned by the OARS Atlas; and moderate pain on
the Western Ontario and McMaster Universities (WOMAC)
arthritis index pain scale. Key exclusion criteria included sec-
ondary OA or signiﬁcant hip arthritis, genu varus or genu val-
gus greater than or equal to OARS grade 2 for malalignment
of either knee, erosive/inﬂammatory OA, history of signiﬁcant
surgery to the target knee, septic arthritis of the target knee,
traumatic injury to either knee within the last 6 months, joint
lavage of either knee within the 6 months prior to screening,
surgery to either knee within the last year, or a knee replace-
ment in the target knee. The core trial duration was 6 months
followed by an optional extension.
Each knee was exposed on a separate ﬁlm. Positioning
was aided by the use of a Plexiglas frame (SynaFlex, Syn-
arc, Inc.). Imaging QA, image digitization and image analysis
were all performedbya central radiology service, Synarc, Inc.
ImagingQA included production of procedural manuals, cen-
tralized technologist training, and centralized imaging proto-
col compliance and image quality veriﬁcation. Image quality
assessment included anatomical coverage of the knee; posi-
tioning and projection of the joint space; presence of signiﬁ-
cant artifacts; and delineation of cortical and trabecular
bone, particularly the femorotibial articular surfaces. If im-
ages did not meet the QA requirements they were rejected,
and the corresponding patients rescheduled for repeat radi-
ography. The average image rejection rate for the study
was 9.5%. Analog ﬁlm images were bar coded, digitized to
a resolution of 100 m, and stored in a central database. Mini-
mum JSW was measured by the central radiology service
using semi-automated software adapted to meet federal
regulations and integratedwith the central imagedatabase11.
This software automatically delineated the articular surfaces
of themedial and lateral femorotibial compartments andmea-
sured JSWat the point ofminimumdistance in each compart-
ment. Computer measurements were veriﬁed and edited, if
necessary, by a trained radiologist to ensure correct delinea-
tion of the articular surfaces and selection of measurement
sites that excluded marginal osteophytes and that were
restricted to the weight-bearing portions of the femorotibial
joints. Images were measured individually rather than in se-
rial pairs, and the radiologistswere blinded to patient informa-
tion and the chronology of the images.
SEMI-FLEXED METATARSOPHALANGEAL (MTP) TECHNIQUE
The MTP technique12 was utilized in the Bayer trial, which
included 112 placebo patients who were >45 years of age,
recruited from 58 clinical sites, and radiographed at 22 imag-
ing hubs in North America. A target knee was identiﬁed by
selecting a knee with symptomatic primary or post-traumatic
(>6 months) pain at least 50% of the days in the month prior
to the ﬁrst visit, KellgreneLawrence (KeL) radiographic
grades 2e3 with a 2 mm minimum medial compartment
JSW with an osteophyte in either compartment, and medial
or bicompartmental JSN. Key exclusion criteria included
the presence of lateral compartment disease only, OA sec-
ondary to a known disorder, or lower limb surgery, arthros-
copy, aspiration, or lavage in any lower limb joint within the
last 6 months. The true target knee was selected utilizing
the symptomatic information for each patient. However, the
target knee information was not available for this summary.
Thus, the target knee for this summary was deﬁned as the
knee with the smallest baseline medial minimum JSW
greater than zero. This criterion allowed the inclusion of all
the placebo patients for this summary. The duration of this
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uled at baseline, and 12, 18, 24, 30, and 36 months.
Both knees were exposed together on a single ﬁlm. Re-
peat positioning was aided by hand-drawn foot maps for
each patient. Imaging QA included production of procedural
manuals, centralized technologist training and centralized
imaging compliance and image quality veriﬁcation. This,
along with radiographic eligibility assessments, image digi-
tization, and bar coding were performed by the same central
radiology service (Synarc, Inc.) as for the FF study. JSW
measurements were performed by the same central analy-
sis facility, Kings College London, using an earlier version
of the semi-automated software that was used in the Fluoro
study13. Computer measurements were veriﬁed and occa-
sionally edited to ensure correct delineation of the articular
surfaces and selection of measurement sites that excluded
marginal osteophytes and that were restricted to the weight-
bearing portions of the femorotibial joints. Images were
measured individually rather than in serial pairs, and
readers were blind to patient information and the chronol-
ogy of the images. Additionally, two measurements were
provided for each time point since two radiographs of both
knees were obtained at each visit. The average of the two
measurements was used in the summaries. This approach
yields the best estimate for the JSW. The standard devia-
tion (SD) estimates obtained from two X-rays per patient
are similar to those obtained from one X-ray per patient. Us-
ing the average values from two X-rays decreased the SD
by approximately 0.02 mm. In contrast, the Fluoro and FF
studies used only single measurements at each time point.
Results
The placebo patients in all three trials were similar with
respect to gender and age. Approximately two-thirds of
the patients in each of the three trials were female (Fluoro
64%, FF 69%, and MTP 67%) and the average (SD)
age ranged from 59 to 63 years (Fluoro 63 7.9 years,
FF 59 7.7 years, MTP 63 9.1 years). The mean (SD)
baseline minimum JSW was between 3 and 4 mm in all
three groups (Fluoro 3.07 0.486 mm, FF 3.79 0.928 mm,
MTP 3.27 0.935 mm). The baseline minimum JSW values
ranged from 1.95 to 3.90 mm in the Fluoro group, 2.02 to
7.14 mm in the FF group, and 0.85 to 5.53 mm in the
MTP group.
For all patients, the mean (median) change in JSW over
time in the three groups ranged from a decrease of 0.12 mm
(0.05 mm) to an increase of 0.07 mm (0.09 mm) (Table I).
For the subgroups of patients with a baseline JSW between
2 and 4 mm, the mean (median) change in JSW over time inthe three groups ranged from a decrease of 0.12 mm
(0.05 mm) to an increase of 0.1 mm (0.10 mm). The Fluoro
study showed the greatest magnitude of OA structural pro-
gression and the lowest variability. The Fluoro study was
expected to show the greatest magnitude of structural pro-
gression since it was conducted for the longest duration.
P-values for change in JSW were not calculated because
of the differences in observation times (Table II) and other
factors among the studies.
As noted in Table II, patients in the Fluoro group were ob-
served for 0.98 years on average. As expected, this group
had the lowest variability in duration of observation because
the study was completed. Mean (SD) duration of observa-
tion for the FF group was 0.68 0.225 years and for the
MTP group was 0.82 0.250 years. These two studies
were stopped early.
Without considering duration of observation, the propor-
tion of patients with various degrees of JSN over time
was similar for all three groups (Tables III and IV).
Discussion
All three radiographic techniques conﬁrm the existence of
a subset of patients with detectable disease progression.
The change in JSW distribution was non-normal for the
Fluoro and MTP studies. Differences in entry criteria and
study duration preclude meaningful comparisons of progres-
sion, variability, and radiographic methods. However, the
summaries give some insight into the progression and vari-
ability when weighing all of the confounding factors. In the
Fluoro and MTP studies, the mean changes from baseline
JSW are less than the median changes from baseline JSW,
indicating a skewed distribution for JSN in these studies.
The skewness for theMTP study becomes evenmore evident
when the outlier (an increase of 2.96 mm) is removed. A
similar distribution of the change in JSW, alsomeasured using
the Fluoro method, has been shown by Mazzuca et al. in
a 2.5-year study14. The skewed nature of JSN indicates that
summaries and analyses based on mean values may not
always be appropriate. Alternative analyses and summaries
may be more appropriate for skewed distributions.
Both the Fluoro and the MTP studies required that the
medial compartment be narrower than the lateral compart-
ment, although the latter study included patients whose
knees exhibited bicompartmental disease. These criteria
were determined by visual inspection. However, the FF
study did not have these criteria. The effect of these criteria
could be estimated by removing any FF patients who had
a computerized baseline lateral JSW measurement that
was smaller than the measurement for the medialTable I
Change in JSW in subjects receiving placebo by method of measurement stratified by baseline JSW
Method Subjects Mean (mm) SD (mm) Median (mm) Minimum (mm) Maximum (mm)
Fluoro All subjects, N¼ 85 0.12 0.417 0.05 2.06 0.47
FF All subjects, N¼ 99 0.07 0.630 0.09 2.11 2.60
Baseline JSW 2e4 mm, N¼ 63 0.11 0.690 0.10 1.92 2.60
Baseline JSW 2e4 mm and medial
compartment< lateral compartment, N¼ 62
0.11 0.695 0.11 1.92 2.60
MTP All subjects, N¼ 112 0.00 0.525 0.03 1.28 2.96
All subjects except outlier, N¼ 111 0.03 0.445 0.03 1.28 1.12
Baseline JSW 2e4 mm, N¼ 76 0.06 0.523 0.06 1.15 2.96
Note: A negative change indicates a decrease in JSW. Caution should be used in comparing these numbers since the duration of obser-
vation varies by method of measurement.
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currence and there was not a visual inspection for conﬁrma-
tion in all ﬁlms, the effect of this criterion is unknown in
these data. However, this difference in the inclusion criteria
could at least partially explain why the changes in JSW for
the Fluoro and MTP groups were not normally distributed
and the changes in JSW for the FF group were normally dis-
tributed since patients with primarily lateral compartment
progression in the FF group may have had a resulting
increase in the JSW of the medial compartment.
Differences among the studies in progression and variabil-
ity may be attributed to various potential effects among the
cohorts. For example, the FF patients had the widest range
of baseline JSW; the FF study excluded patients with joints
with varus or valgus deformities; and the MTP study included
patients with post-traumatic knees. The target knee for the
analysis of the MTP study was based on how narrow the
baseline JSW was without regard to pain, whereas the Flu-
oro and FF studies selected the target knee based on pain.
Additionally, differences in the QA methodology between
Fluoro and non-Fluoro methods may have had an effect on
the measured progression and the variability. Differences
in the JSW measurement methods, e.g., where JSW was
measured, the software used, and the degree and circum-
stances of manipulation of original computerized measure-
ments, could have an effect.
In the Fluoro study almost all patients were followed for 1
year as planned. This was not the case in the studies using
non-Fluoro methods. In the MTP and FF studies, patients
were followed in many cases for just a few months. The pa-
tients in the FF study were to be observed for the shortest pe-
riod of time, 6 months in the original trial followed by an
optional extension. In a disease as slow moving as OA and
in which the methods of measurement are as sensitive as
possible to detect changes in the joint space, the method in-
evitably will also detect inherent anatomical variability in joint
positioning during radiography. Thus, radiographs taken
after greater time intervals will be more likely to capture the
Table II
Duration of observation by method of measurement
Method Duration of
observation (years)
Fluoro, N¼ 85
Mean (SD) 0.98 (0.026)
Median 0.98
Min, max 0.92, 1.10
FF, N¼ 99
Mean (SD) 0.68 (0.225)
Median 0.55
Min, max 0.40, 1.08
MTP, N¼ 112
Mean (SD) 0.82 (0.250)
Median 0.90
Min, max 0.12, 1.31
Table III
Proportion of patients with JSN over time by method of measurement
Method n, %
0.5 mm 0.75 mm 1.0 mm 1.25 mm
Fluoro, N¼ 85 9, 11 5, 6 3, 4 3, 4
FF, N¼ 99 12, 12 10, 10 5, 5 3, 3
MTP, N¼ 112 15, 13 7, 6 4, 4 1, 1natural disease progression in patients and will potentially in-
crease the variability of the measured progression.
Measurement variability was inﬂuenced by data from pa-
tients who had an increase in knee joint space, which was
described also by Mazucca et al. in their Fluoro study14. Po-
tential reasons for increases in JSW measurements from
semi-ﬂexed knee ﬁlms, other than measurement error, are
discussed elsewhere in this issue by Buckland-Wright15.
Apart from the possibility that cartilage may have under-
gone some repair, factors that can account for these obser-
vations include an increase in medial compartment JSW
due to OA progression occurring mainly in the lateral com-
partment and ligament laxity from articular cartilage loss in
knees with advanced OA, resulting in joint subluxation. Be-
cause of the focal nature of articular cartilage loss in OA,
joint subluxation leads to the displacement of the femur
upon the tibia and an altered site for JSW measurement
at successive radiographic examinations. Joint subluxation
associated with ligament laxity can also result in the entrap-
ment of all or part of the meniscus in the medial compart-
ment. This would lead to a marked increase or decrease
in JSW measurement between successive radiographs,
which is one plausible reason for the marked JSW changes
shown recently by Brandt et al.7.
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